• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[不同类型免疫纠正疗法对慢性粒细胞白血病临床病程的影响]

[The effect of different types of immunocorrective therapy on the clinical course of chronic myeloleukemia].

作者信息

Guseva S A

出版信息

Lik Sprava. 1993 Oct-Dec(10-12):45-7.

PMID:8030307
Abstract

Influence of various patterns of immunocorrective therapy on clinical course of chronic myeloleukemia (CML) was studied. It was shown that combinations of drugs with different pharmacological effects provide more than 5-fold decrease in incidence of infection-related complications and promote rapid recovery from infections during antibacterial treatment.

摘要

研究了各种免疫纠正疗法模式对慢性粒细胞白血病(CML)临床病程的影响。结果表明,具有不同药理作用的药物组合可使感染相关并发症的发生率降低5倍以上,并促进抗菌治疗期间感染的快速恢复。

相似文献

1
[The effect of different types of immunocorrective therapy on the clinical course of chronic myeloleukemia].[不同类型免疫纠正疗法对慢性粒细胞白血病临床病程的影响]
Lik Sprava. 1993 Oct-Dec(10-12):45-7.
2
[Effect of proper-myl on humoral interactions between activated lymphocytes and neutrophils in patients with myeloproliferative diseases].[丙戊酸对骨髓增殖性疾病患者活化淋巴细胞与中性粒细胞间体液相互作用的影响]
Antibiot Khimioter. 1991 Jan;36(1):35-7.
3
[Clinico-immunologic effect of tactivin in chronic myeloid leukemia].[促活素对慢性髓性白血病的临床免疫效应]
Gematol Transfuziol. 1994 Sep-Oct;39(5):19-22.
4
[Effect of prodigiozan on the antibody-dependent cytotoxicity of neutrophils in chronic myeloid leukemia].[灵菌红素对慢性髓性白血病中性粒细胞抗体依赖性细胞毒性的影响]
Vopr Onkol. 1989;35(1):30-4.
5
[Comparative study of the effectiveness of immunomodulating preparations in combined therapy of chronic obstructive bronchitis].[免疫调节制剂在慢性阻塞性支气管炎联合治疗中的有效性比较研究]
Klin Med (Mosk). 1995;73(4):88-90.
6
Autografting in chronic myelogenous leukemia followed by immunotherapy.慢性粒细胞白血病自体移植后进行免疫治疗。
Stem Cells. 1993 Oct;11 Suppl 3:34-42. doi: 10.1002/stem.5530110911.
7
[Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].[在皮肤病学中使用活性胸腺因子(taktivin)进行免疫纠正治疗的前景]
Vestn Dermatol Venerol. 1986(4):4-7.
8
[Principles of immunocorrective therapy using the thymus preparation T-activin].[使用胸腺制剂T-激活素的免疫纠正疗法原理]
Khirurgiia (Mosk). 1984 Nov(11):44-8.
9
[Use of the stimulants of nonspecific resistance in the complex treatment of infectious complications in patients with chronic myeloid leukemia].[非特异性抵抗力刺激剂在慢性髓细胞白血病患者感染性并发症综合治疗中的应用]
Gematol Transfuziol. 1991 Aug;36(8):21-3.
10
[Taktivin in the combined treatment of patients with ovarian cancer].
Akush Ginekol (Mosk). 1988 Aug(8):57-61.